Cell Reactant:
Flavin reductase (NADPH)
Syringe Reactant:
BDBM79514
Meas. Tech.:
Enzyme Inhibition
Entry Date.:
2023-10-06
ΔG°:
-9.31±0.11 (kcal/mole)
Temperature:
298.1500±0.0000 (K)
ΔH° :
-6.39±0.07 (kJ/mole)
ΔS° :
0.01±0 (kJ/mole-K)
Citation
 Ryu, KKim, MGriesinger, CLee, D Method of increasing platelet counts of a subject US Patent  US11744839 Publication Date 9/5/2023 
Cell React
Name:
Flavin reductase (NADPH)
Synonyms:
BLVRB_HUMAN | BLVRB | FLR | 1.3.1.24 | 1.5.1.30 | BVR-B | Biliverdin reductase B | Biliverdin-IX beta-reductase
Type:
PROTEIN
Mol. Mass.:
22123.63
Organism:
Human
Description:
ChEMBL_100283
Residue:
206
Sequence:
MAVKKIAIFGATGQTGLTTLAQAVQAGYEVTVLVRDSSRLPSEGPRPAHVVVGDVLQAADVDKTVAGQDAVIVLLGTRNDLSPTTVMSEGARNIVAAMKAHGVDKVVACTSAFLLWDPTKVPPRLQAVTDDHIRMHKVLRESGLKYVAVMPPHIGDQPLTGAYTVTLDGRGPSRVISKHDLGHFMLRCLTTDEYDGHSTYPSHQYQ
  
Syringe React
Name:
BDBM79514
Synonyms:
sodium;2-(2,4,5,7-tetraiodo-3-oxido-6-oxo-9-xanthenyl)benzoate | cid_25162930 | SMR000875321 | Erythrosin B | sodium;2-[2,4,5,7-tetrakis(iodanyl)-3-oxidanidyl-6-oxidanylidene-xanthen-9-yl]benzoate | sodium;2-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate | MLS001335987 | sodium;2-(2,4,5,7-tetraiodo-3-keto-6-oxido-xanthen-9-yl)benzoate | US11744839, Compound Erythrosin B
Type:
Small organic molecule
Emp. Form.:
TBD
Mol. Mass.:
TBD
SMILES:
TBD
Structure:
Search PDB for entries with ligand similarity: